Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Feb 07, 2020 SC 13G A statement of beneficial ownership of common stock by certain persons View HTML
0000834237-20-007999.pdf
0000834237-20-007999.rtf
Feb 07, 2020 SC 13G/A An amendment to the SC 13G filing View HTML
0000315066-20-000935.pdf
0000315066-20-000935.rtf
Jan 29, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001628280-20-000685.pdf
0001628280-20-000685.rtf
0001628280-20-000685.xls
Jan 29, 2020 424B5 Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 View HTML
0001628280-20-000680.pdf
0001628280-20-000680.rtf
0001628280-20-000680.xls
Jan 27, 2020 424B5 Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 View HTML
0001628280-20-000564.pdf
0001628280-20-000564.rtf
0001628280-20-000564.xls
Jan 27, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001628280-20-000565.pdf
0001628280-20-000565.rtf
0001628280-20-000565.xls
Jan 16, 2020 SC 13G/A An amendment to the SC 13G filing View HTML
0001088875-20-000010.pdf
0001088875-20-000010.rtf
Jan 14, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001714899-20-000005.pdf
0001714899-20-000005.rtf
0001714899-20-000005.xls
Dec 23, 2019 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-19-061843.pdf
0001209191-19-061843.rtf
Dec 05, 2019 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-19-059302.pdf
0001209191-19-059302.rtf
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 49
  • Page 50
  • Current page 51
  • Page 52
  • Page 53
  • …
  • Next page ›
  • Last page »
Displaying 501 - 510 of 696 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use